Sunlight protection by vitamin D compounds

Vitamin D

Volumn , Issue , 2011, Pages 1943-1953

  Mason, Rebecca S ^a   Dixon, Katie M ^a   Sequeira, Vanessa B ^a   Gordon Thomson, Clare ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884787364     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10100-3     Document Type: Chapter

References (119)

1. Matsumura Y., Ananthaswamy H.N. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev. Mol. Med. 2002, 4:1-22.
2. Eller M.S., Maeda T., Magnoni C., Atwal D., Gilchrest B.A. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl. Acad. Sci. USA 1997, 94:12627-12632.
3. Kochevar I.E., Pathak M.A., Parrish J.A. Photophysics, photochemistry, and photobiology. Fitzpatrick's Dermatology in General Medicine 1999, McGraw Hill, Health Provisions Division, New York. fifth ed.
4. Mason R.S., Sequeira V.B., Dixon K.M., Gordon-Thomson C., Pobre K., Dilley A., et al. Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage. J. Steroid Biochem. Mol. Biol. 2010, 121:164-168.
5. Bikle D.D., Nemanic M.K., Gee E., Elias P. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J. Clin. Invest. 1986, 78:557-566.
6. Lehmann B., Genehr T., Knuschke P., Pietzsch J., Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J. Invest. Dermatol. 2001, 117:1179-1185.
7. Cooke M.S., Podmore I.D., Mistry N., Evans M.D., Herbert K.E., Griffiths H.R., et al. Immunochemical detection of UV-induced DNA damage and repair. J. Immunol. Methods 2003, 280:125-133.
8. Mitchell D.L., Cleaver J.E., Epstein J.H. Repair of pyrimidine (6-4) pyrimidone photoproducts in mouse skin. J. Invest. Dermatol. 1990, 95:55-59.
9. Halliday G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res. 2005, 571:107-120.
10. Bruch-Gerharz D., Ruzicka T., Kolb-Bachofen V. Nitric oxide in human skin: current status and future prospects. J. Invest. Dermatol. 1998, 110:1-7.
11. Cals-Grierson M.M., Ormerod A.D. Nitric oxide function in the skin. Nitric Oxide 2004, 10:179-193.
12. Deliconstantinos G., Villiotou V., Stavrides J.C. Alterations of nitric oxide synthase and xanthine oxidase activities of human keratinocytes by ultraviolet B radiation. Potential role for peroxynitrite in skin inflammation. Biochem. Pharmacol. 1996, 51:1727-1738.
13. Hess D.T., Matsumoto A., Nudelman R., Stamler J.S. S-nitrosylation: spectrum and specificity. Nat. Cell Biol. 2001, 3:E46-49.
14. Mowbray M., McLintock S., Weerakoon R., Lomatschinsky N., Jones S., Rossi A.G., et al. Enzyme-independent NO stores in human skin: quantification and influence of UV radiation. J. Invest. Dermatol. 2009, 129:834-842.
15. Paunel A.N., Dejam A., Thelen S., Kirsch M., Horstjann M., Gharini P., et al. Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. Free Radic. Biol. Med. 2005, 38:606-615.
16. McAndrew J., Patel R.P., Jo H., Cornwell T., Lincoln T., Moellering D., et al. The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease. Seminars in Perinatology 1997, 21:351-366.
17. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
18. Burney S., Caulfield J.L., Niles J.C., Wishnok J.S., Tannenbaum S.R. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 1999, 424:37-49.
19. Niles J.C., Wishnok J.S., Tannenbaum S.R. Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide 2006, 14:109-121.
20. Ohshima H., Sawa T., Akaike T. 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid. Redox. Signal 2006, 8:1033-1045.
21. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991, 254:1001-1003.
22. Matsumura Y., Ananthaswamy H.N. Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 2004, 195:298-308.
23. Agar N.S., Halliday G.M., Barnetson R.S., Ananthaswamy H.N., Wheeler M., Jones A.M. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl. Acad. Sci. USA 2004, 101:4954-4959.
24. Murata J., Tada M., Iggo R.D., Sawamura Y., Shinohe Y., Abe H. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat. Res. 1997, 379:211-218.
25. Ambs S., Bennett W.P., Merriam W.G., Ogunfusika M.O., Oser S.M., Harrington A.M., et al. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst. 1999, 91:86-88.
26. Schul W., Jans J., Rijksen Y.M., Klemann K.H., Eker A.P., de Wit J., et al. Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice. EMBO J. 2002, 21:4719-4729.
27. McGregor W.G. DNA repair, DNA replication, and UV mutagenesis. J. Invest. Dermatol. Symp. Proc. 1999, 4:1-5.
28. Brash D.E., Ziegler A., Jonason A.S., Simon J.A., Kunala S., Leffell D.J. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J. Invest. Dermatol. Symp. Proc. 1996, 1:136-142.
29. Nataraj A.J., Trent J.C., Ananthaswamy H.N. p53 gene mutations and photocarcinogenesis. Photochem. Photobiol. 1995, 62:218-230.
30. Soehnge H., Ouhtit A., Ananthaswamy O.N. Mechanisms of induction of skin cancer by UV radiation. Front Biosci. 1997, 2:d538-551.
31. Hall P.A., McKee P.H., Menage H.D., Dover R., Lane D.P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene. 1993, 8:203-207.
32. Saito S., Yamaguchi H., Higashimoto Y., Chao C., Xu Y., Fornace A.J., et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 2003, 278:37536-37544.
33. Berg R.J., van Kranen H.J., Rebel H.G., de Vries A., van Vloten W.A., Van Kreijl C.F., et al. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc. Natl. Acad. Sci. USA 1996, 93:274-278.
34. Momand J., Wu H.H., Dasgupta G. MDM2 - master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29.
35. Ouhtit A., Muller H.K., Davis D.W., Ullrich S.E., McConkey D., Ananthaswamy H.N. Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. Am. J. Pathol. 2000, 156:201-207.
36. Hussein M.R. Ultraviolet radiation and skin cancer: molecular mechanisms. J. Cutan. Pathol. 2005, 32:191-205.
37. Mullauer L., Gruber P., Sebinger D., Buch J., Wohlfart S., Chott A. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mut. Res. 2001, 488:211-231.
38. Amundson S.A., Patterson A., Do K.T., Fornace A.J. A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther. 2002, 1:145-149.
39. Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA 1999, 96:424-428.
40. Carrier F., Georgel P.T., Pourquier P., Blake M., Kontny H.U., Antinore M.J., et al. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol. Cell Biol. 1999, 19:1673-1685.
41. Bau D.T., Gurr J.R., Jan K.Y. Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision. Carcinogenesis 2001, 22:709-716.
42. Jaiswal M., LaRusso N.F., Burgart L.J., Gores G.J. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000, 60:184-190.
43. Kuchel J.M., Barnetson R.S., Halliday G.M. Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochem. Photobiol. Sci. 2005, 4:577-582.
44. Kripke M.L., Fisher M.S. Immunologic parameters of ultraviolet carcinogenesis. J. Natl. Cancer Inst. 1976, 57:211-215.
45. Nghiem D.X., Kazimi N., Mitchell D.L., Vink A.A., Ananthaswamy H.N., Kripke M.L., et al. Mechanisms underlying the suppression of established immune responses by ultraviolet radiation. J. Invest. Dermatol. 2002, 119:600-608.
46. Rana S., Byrne S.N., MacDonald L.J., Chan C.Y., Halliday G.M. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am. J. Pathol. 2008, 172:993-1004.
47. Simon J.C., Cruz P.D., Tigelaar R.E., Sontheimer R.D., Bergstresser P.R. Adhesion molecules CD11a, CD18, and ICAM-1 on human epidermal Langerhans cells serve a functional role in the activation of alloreactive T cells. J. Invest. Dermatol. 1991, 96:148-151.
48. Tang A., Udey M.C. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells. J. Immunol. 1991, 146:3347-3355.
49. Toews G.B., Bergstresser P.R., Streilein J.W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 1980, 124:445-453.
50. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 2007, 8:1095-1104.
51. Nishimura N., Tohyama C., Satoh M., Nishimura H., Reeve V.E. Defective immune response and severe skin damage following UVB irradiation in interleukin-6-deficient mice. Immunology 1999, 97:77-83.
52. Halliday G.M., Norval M., Byrne S.N., Huang X., Wolf P. The effects of sunlight on the skin. Drug Discovery Today:. Disease Mechanisms 2008, 5:e201-e209.
53. Dixon K.M., Sequeira V.B., Camp A.J., Mason R.S. Vitamin D-fence. Photochem. Photobiol. Sci. 2010, 9:564-570.
54. Melnikova V.O., Ananthaswamy H.N. Cellular and molecular events leading to the development of skin cancer. Mutat. Res. 2005, 571:91-106.
55. Leffell D.J., Brash D.E. Sunlight and skin cancer. Sci. Am. 1996, 275(52-53):56-59.
56. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., et al. Sunburn and p53 in the onset of skin cancer. Nature 1994, 372:773-776.
57. Zambetti G.P., Levine A.J. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 1993, 7:855-865.
58. Matsumura Y., Ananthaswamy H.N. Molecular mechanisms of photocarcinogenesis. Front. Biosci. 2002, 7:d765-783.
59. Javeri A., Huang X.X., Bernerd F., Mason R.S., Halliday G.M. Human 8-oxoguanine-DNA glycosylase 1 protein and gene are expressed more abundantly in the superficial than basal layer of human epidermis. DNA. Repair (Amst.) 2008, 7:1542-1550.
60. Yasui M., Suenaga E., Koyama N., Masutani C., Hanaoka F., Gruz P., et al. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA adduct, during translesion synthesis catalyzed by human DNA polymerases. J. Mol. Biol. 2008, 377:1015-1023.
61. Ding W., Hudson L.G., Sun X., Feng C., Liu K.J. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radic. Biol. Med. 2008, 45:1065-1072.
62. Hoxtell E.O., Mandel J.S., Murray S.S., Schuman L.M., Goltz R.W. Incidence of skin carcinoma after renal transplantation. Arch. Dermatol. 1977, 113:436-438.
63. Moloney F.J., Comber H., O'Lorcain P., O'Kelly P., Conlon P.J., Murphy G.M. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br. J. Dermatol. 2006, 154:498-504.
64. Hill B.H. Immunosuppressive drug therapy as a potentiator of skin tumours in five patients with lymphoma. Australas. J. Dermatol. 1976, 17:46-48.
65. Lehmann B., Rudolph T., Pietzsch J., Meurer M. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents. Exp. Dermatol. 2000, 9:97-103.
66. Lehmann B., Tiebel O., Meurer M. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents - a preliminary study. Arch. Dermatol. Res. 1999, 291:507-510.
67. Vantieghem K., De Haes P., Bouillon R., Segaert S. Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation. J. Photochem. Photobiol. B. 2006, 85:72-78.
68. Holick M.F., MacLaughlin J.A., Clark M.B., Holick S.A., Potts J.T., Anderson R.R., et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980, 210:203-205.
69. Janjetovic Z., Zmijewski M.A., Tuckey R.C., DeLeon D.A., Nguyen M.N., Pfeffer L.M., et al. 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One 2009, 4:e5988.
70. Slominski A.T., Zmijewski M.A., Semak I., Sweatman T., Janjetovic Z., Li W., et al. Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PLoS One 2009, 4:e4309.
71. 3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 2001, 66:147-158.
72. Hanada K., Sawamura D., Nakano H., Hashimoto I. Possible role of 1,25-dihydroxyvitamin D3-induced metallothionein in photoprotection against UVB injury in mouse skin and cultured rat keratinocytes. J. Dermatol. Sci. 1995, 9:203-208.
73. Claerhout S., Van Laethem A., Agostinis P., Garmyn M. Pathways involved in sunburn cell formation: deregulation in skin cancer. Photochem. Photobiol. Sci. 2006, 5:199-207.
74. Sheehan J.M., Young A.R. The sunburn cell revisited: an update on mechanistic aspects. Photochem. Photobiol. Sci. 2002, 1:365-377.
75. Youn J.I., Park B.S., Chung J.H., Lee J.H. Photoprotective effect of calcipotriol upon skin photoreaction to UVA and UVB. Photodermatol. Photoimmunol. Photomed. 1997, 13:109-114.
76. Lee J., Youn J.I. The photoprotective effect of 1,25-dihydroxyvitamin D3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action. J. Dermatol. Sci. 1998, 18:11-18.
77. De Haes P., Garmyn M., Degreef H., Vantieghem K., Bouillon R., Segaert S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J. Cell Biochem. 2003, 89:663-673.
78. Manggau M., Kim D.S., Ruwisch L., Vogler R., Korting H.C., Schafer-Korting M., et al. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J. Invest. Dermatol. 2001, 117:1241-1249.
79. Mason R.S., Holliday C.J. 1,25 Dihydroxyvitamin D contributes to photoprotection in skin cells. Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects 2000, University of California, Riverside.
80. Mason R.S., Holliday C.J., Gupta R. 1,25 Dihydroxyvitamin D and photoprotection in skin cells. Modern Trends in Skin Pharmacology 2002, Parissianos Medical Publications, Athens, Greece.
81. Dixon K.M., Deo S.S., Norman A.W., Bishop J.E., Halliday G.M., Reeve V.E., et al. In vivo relevance for photoprotection by the vitamin D rapid response pathway. J. Steroid Biochem. Mol. Biol. 2007, 103:451-456.
82. Gupta R., Dixon K.M., Deo S.S., Holliday C.J., Slater M., Halliday G.M., et al. Photoprotection by 1,25dihydroxyvitamin D is associated with an increase in p53 and a decrease in nitric oxide products. J. Invest. Dermatol. 2007, 127:707-715.
83. Damian D., Kim Y.J., Dixon K., Halliday G.M., Javeri A., Mason R.S. Topical calcitriol protects from UV-induced genetic damage but suppresses immunity in humans. Exp. Dermatol. 2010, 19:e23-e30.
84. Wong G., Gupta R., Dixon K.M., Deo S.S., Choong S.M., Halliday G.M., et al. 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway. J. Steroid Biochem. Mol. Biol. 2004, 89-90:567-570.
85. Diker-Cohen T., Koren R., Liberman U.A., Ravid A. Vitamin D protects keratinocytes from apoptosis induced by osmotic shock, oxidative stress, and tumor necrosis factor. Ann. NY. Acad. Sci. 2003, 1010:350-353.
86. Ravid A., Rubinstein E., Gamady A., Rotem C., Liberman U.A., Koren R. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J. Endocrinol. 2002, 173:525-532.
87. Rocker D., Ravid A., Liberman U.A., Garach-Jehoshua O., Koren R. 1,25-Dihydroxyvitamin D3 potentiates the cytotoxic effect of TNF on human breast cancer cells. Mol. Cell Endocrinol. 1994, 106:157-162.
88. De Haes P., Garmyn M., Verstuyf A., De Clercq P., Vandewalle M., Degreef H., et al. 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. Photochem. Photobiol. Sci. B. Biol. 2005, 78:141-148.
89. Dixon K.M., Deo S.S., Wong G., Slater M., Norman A.W., Bishop J.E., et al. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J. Steroid Biochem. Mol. Biol. 2005, 97:137-143.
90. Mitani H., Naru E., Yamashita M., Arakane K., Suzuki T., Imanari T. Ergocalciferol promotes in vivo differentiation of keratinocytes and reduces photodamage caused by ultraviolet irradiation in hairless mice. Photodermatol. Photoimmunol. Photomed. 2004, 20:215-223.
91. Biggs L., Yu C., Fedoric B., Lopez A.F., Galli S.J., Grimbaldeston M.A. J. Exp. Med. 2010, 207:455-463.
92. Matheu V., Back O., Mondoc E., Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 2003, 112:585-592.
93. Hanneman K.K., Scull H.M., Cooper K.D., Baron E.D. Effect of topical vitamin D analogue on in vivo contact sensitization. Arch. Dermatol. 2006, 142:1332-1334.
94. Gorman S., Kuritzky L.A., Judge M.A., Dixon K.M., McGlade J.P., Mason R.S., et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 2007, 179:6273-6283.
95. Ellison T.I., Smith M.K., Gilliam A.C., MacDonald P.N. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J. Invest. Dermatol. 2008, 128:2508-2517.
96. Wood A.W., Chang R.L., Huang M.T., Uskokovic M., Conney A.H. 1 Alpha, 25-dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem. Biophys. Res. Commun. 1983, 116:605-611.
97. Kensler T.W., Dolan P.M., Gange S.J., Lee J.K., Wang Q., Posner G.H. Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis. Carcinogenesis 2000, 21:1341-1345.
98. Dixon K.M. Photoprotective effects and mechanisms of action of vitamin D and its analogues. Honours thesis. Department of Physiology 2003, University of Sydney, Sydney, Australia.
99. Sequeira V.B., Mason R.S. Mechanisms of the photoprotective effect of 1,25 dihydroxyvitamin D. Conference abstract. J. Invest. Dermatol. 2009, 129:2915.
100. De Haes P., Garmyn M., Verstuyf A., De Clercq P., Vandewalle M., Vantieghem K., et al. Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB. Arch. Dermatol. Res. 2004, 295:527-534.
101. Peus D., Vasa R.A., Beyerle A., Meves A., Krautmacher C., Pittelkow M.R. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J. Invest. Dermatol. 1999, 112:751-756.
102. Wang H.Q., Quan T., He T., Franke T.F., Voorhees J.J., Fisher G.J. Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes. J. Biol. Chem. 2003, 278:45737-45745.
103. Sequeira V.B., Reeve V.E., Halliday G.M., Mason R.S. Signalling pathways involved in photoprotection by 1,25 dihydroxyvitamin D 2008, The 4th Australian Health and Medical Research Congress Mutagenesis and Experimental Pathology Society of Australia, Brisbane, Australia, p 169.
104. Zanello L.P., Norman A.W. Multiple molecular mechanisms of 1 alpha,25(OH)2-vitamin D3 rapid modulation of three ion channel activities in osteoblasts. Bone 2003, 33:71-79.
105. Hanada K., Gange R.W., Siebert E., Hasan T. Protective effects of cadmium chloride against UVB injury in mouse skin and in cultured human cells: a possible role of cadmium-induced metallothionein. Photodermatol. Photoimmunol. Photomed. 1991, 8:111-115.
106. Karasawa M., Hosoi J., Hashiba H., Nose K., Tohyama C., Abe E., et al. Regulation of metallothionein gene expression by 1 alpha,25-dihydroxyvitamin D3 in cultured cells and in mice. Proc. Natl. Acad. Sci. USA 1987, 84:8810-8813.
107. Bijlsma M.F., Spek C.A, Zivkovic D., van de Water S., Rezaee F., Peppelenbosch M.P. Repression of smoothened by patched-dependent (pro-) vitamin D3 secretion. PLos Biol. 2006, 4:e232.
108. Bruggemann L.W., Queiroz K.C.S, Zamani K., van Straaten A., Spek C.A., Bijlsma M.F. Assessing the efficacy of the hedgehog pathway inhibitor vitamin D3 in a murine xenograft model for pancreatic cancer. Cancer Biol. Ther. 2010, 10:79-88.
109. Dharmadasa T., Malley R., Woods G.M. Dietary vitamin D3 deficiency alters skin UVB-induced DNA damage in neonatal mice 2006, Australian Health and Medical Research Congress, Melbourne, Australia, p 466.
110. Armstrong B.K., Kricker A. The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B. 2001, 63:8-18.
111. Carless M.A., Kraska T., Lintell N., Neale R.E., Green A.C., Griffiths L.R. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. Br. J. Dermatol. 2008, 159:804-810.
112. Han J., Colditz G.A., Hunter D.J. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 2007, 28:390-397.
113. Halsall J.A., Osborne J.E., Potter L., Pringle J.H., Hutchinson P.E. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. Br. J. Cancer 2004, 91:765-770.
114. Li C., Liu Z., Zhang Z., Strom S.S., Gershenwald J.E., Prieto V.G., et al. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J. Invest. Dermatol. 2007, 127:276-280.
115. Randerson-Moor J.A., Taylor J.C., Elliott F., Chang Y.M., Beswick S., Kukalizch K., et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur. J. Cancer 2009, 45:3271-3281.
116. Hutchinson P.E., Osborne J.E., Lear J.T., Smith A.G., Bowers P.W., Morris P.N., et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin. Cancer Res. 2000, 6:498-504.
117. Newton-Bishop J.A., Beswick S., Randerson-Moor J., Chang Y.M., Affleck P., Elliott F., et al. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J. Clin. Oncol. 2009, 27:5439-5444.
118. Santonocito C., Capizzi R., Concolino P., Lavieri M.M., Paradisi A., Gentileschi S., et al. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br. J. Dermatol. 2007, 156:277-282.
119. Halsall J.A., Osborne J.E., Epstein M.P., Pringle J.H., Hutchinson P.E. The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma. Dermatoendocrinol. 2009, 1:54-57.